5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
12.29%
Revenue growth 50-75% of STERV.HE's 16.90%. Martin Whitman would scrutinize if slower growth is temporary.
No Data
No Data available this quarter, please select a different quarter.
12.29%
Gross profit growth 50-75% of STERV.HE's 20.03%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10783.33%
Other expenses change of 10783.33% while STERV.HE maintains costs. Bruce Berkowitz would investigate efficiency.
15.91%
Operating expenses growth above 1.5x STERV.HE's 10.57%. Michael Burry would check for inefficiency.
15.91%
Total costs growth 1.1-1.25x STERV.HE's 13.37%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
-21.21%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-25.61%
EBITDA decline while STERV.HE shows 26.98% growth. Joel Greenblatt would examine position.
-33.75%
EBITDA margin decline while STERV.HE shows 8.62% growth. Joel Greenblatt would examine position.
-28.57%
Operating income decline while STERV.HE shows 74.72% growth. Joel Greenblatt would examine position.
-36.39%
Operating margin decline while STERV.HE shows 49.45% growth. Joel Greenblatt would examine position.
-45.83%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-100.00%
Pre-tax income decline while STERV.HE shows 63.70% growth. Joel Greenblatt would examine position.
-100.00%
Pre-tax margin decline while STERV.HE shows 40.03% growth. Joel Greenblatt would examine position.
33.33%
Tax expense growth less than half of STERV.HE's 109.49%. David Dodd would verify if advantage is sustainable.
-142.11%
Net income decline while STERV.HE shows 56.75% growth. Joel Greenblatt would examine position.
-137.50%
Net margin decline while STERV.HE shows 34.08% growth. Joel Greenblatt would examine position.
-150.00%
EPS decline while STERV.HE shows 53.85% growth. Joel Greenblatt would examine position.
-150.00%
Diluted EPS decline while STERV.HE shows 53.85% growth. Joel Greenblatt would examine position.
-15.79%
Share count reduction while STERV.HE shows 0.00% change. Joel Greenblatt would examine strategy.
-15.79%
Diluted share reduction while STERV.HE shows 0.00% change. Joel Greenblatt would examine strategy.